How the Body's Natural Defense Peptides Both Fight and Regulate Inflammation | Research

The takeaway

Host defense peptides like cathelicidins and defensins play complex dual roles at inflammation sites — fighting infection while simultaneously modulating the inflammatory response in context-dependent ways.

Dual pro- and anti-inflammatory roles
The same host defense peptide can amplify or suppress inflammation depending on its concentration, tissue context, and receptor interactions — making therapeutic development complex but full of potential.

What the researchers found

Host defense peptides (HDPs), including cathelicidins and defensins, play complex dual roles at inflammation sites — acting as both pro-inflammatory and anti-inflammatory mediators depending on their concentration and context. HDPs provide constitutive protection against microorganisms but are also induced by inflammatory signals in various cells and tissues. Their physicochemical properties and interactions with multiple receptors determine whether they amplify or dampen inflammation. Impaired HDP expression is clinically relevant in several inflammatory diseases.

Why it matters

Understanding how HDPs function at inflammation sites is crucial for developing peptide-based therapies for inflammatory diseases. The dual pro/anti-inflammatory nature of these peptides explains why simply boosting HDPs isn't always beneficial — the dose, timing, and tissue context all matter. This complexity also reveals why HDP-based treatments must be carefully designed to harness their therapeutic potential without triggering unwanted inflammation.

The numbers in context

Covers cathelicidins, defensins, and other HDP families · dual pro- and anti-inflammatory roles · expression varies by cell type and tissue · receptor-mediated immunomodulation · clinical relevance in multiple inflammatory diseases

How the study worked

This is a comprehensive review of the literature on host defense peptide expression and function at sites of inflammation, covering constitutive and inducible expression, immunomodulatory mechanisms, and clinical relevance across various inflammatory conditions.

Who was studied

Review covering HDP biology across multiple cell types, tissues, and inflammatory diseases

What this study cannot tell us

As a review, no new experimental data are presented. The complexity of HDP functions makes it difficult to draw universal conclusions — effects vary by peptide type, concentration, tissue context, and disease state. Translating the dual-role biology of HDPs into therapeutic strategies remains challenging.

How to read the evidence

This is a comprehensive narrative review synthesizing evidence from cell biology, animal models, and clinical studies across multiple inflammatory conditions. It provides a thorough overview of the field but does not present new experimental data.

When this study was published

Published in 2019, this review covers the state of HDP biology at inflammation sites. The field has continued to advance, with increasing focus on therapeutic applications of modified HDPs.

The bigger picture

Host defense peptides sit at the crossroads of innate immunity, inflammation, and tissue repair. As the field of peptide therapeutics grows, understanding how natural HDPs modulate inflammation is essential for designing therapeutic peptides that can treat inflammatory diseases without causing harm. The review highlights that HDP biology is far more nuanced than simple antimicrobial activity — these peptides are master regulators of the immune response.

Questions still open

Can specific HDP analogs be designed to selectively activate anti-inflammatory pathways without the pro-inflammatory effects?
Could measuring HDP levels at inflammation sites serve as diagnostic biomarkers for disease severity?
How do disease-specific alterations in HDP expression contribute to chronic inflammatory conditions?

Common questions

What are host defense peptides?

Host defense peptides (HDPs) are small proteins naturally produced by the body's immune system. The two main families are cathelicidins (like LL-37 in humans) and defensins (alpha and beta types). They were originally discovered for their ability to kill bacteria, viruses, and fungi, but we now know they also regulate immune cell behavior, wound healing, and inflammation.

How can the same peptide be both pro- and anti-inflammatory?

HDPs interact with different receptors at different concentrations. At low levels during early infection, they recruit immune cells and promote inflammation to fight pathogens (pro-inflammatory). At higher levels during later stages, they can suppress excessive inflammation and promote tissue repair (anti-inflammatory). The tissue environment, other immune signals present, and the specific receptors available all influence which role the peptide plays.

Read the original research

Expression and Function of Host Defense Peptides at Inflammation Sites.

International journal of molecular sciences, 21(1)

View on PubMed ↗Publisher’s paper ↗

Citation

Prasad, Suhanya V; Fiedoruk, Krzysztof; Daniluk, Tamara; Piktel, Ewelina; Bucki, Robert. (2019). Expression and Function of Host Defense Peptides at Inflammation Sites.. International journal of molecular sciences, 21(1). https://doi.org/10.3390/ijms21010104